WHO ICTRP trial
Effect of Curcumin on Reducing C-reactive protein in Patients with Ovarian…
TCTR20240319007 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20240319007 |
|---|---|
| Public title | Effect of Curcumin on Reducing C-reactive protein in Patients with Ovarian cancer : A randomized controlled trial |
| Scientific title | Effect of Curcumin on Reducing C-reactive protein in Patients with Ovarian cancer : A randomized controlled trial |
| Primary sponsor | Faculty of Medicine, Khon Kaen University |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Thailand |
| Conditions | Ovarian cancer with adjuvant chemotherapy Ovarian cancer , Adjuvant chemotherapy, Curcumin, C-reactive protein;Ovarian cancer , Adjuvant chemotherapy, Curcumin, C-reactive protein |
| Interventions | Adjuvant chemotherapy with Abhaibhubejhr's curcumin capsules 400 mg/capsule ,per oral 2 tablets , 4 times after breakfast, lunch, dinner and before bed every day for a period of 8 weeks.,Adjuvant chemotherapy alone;Experimental… |
| Registration date | Mar 19, 2024 |
| Target size | 52 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: